JayWCarlsonDOMS
Obstetrics & Gynecology • Springfield, MOGynecologic Oncology
Director, Women's Oncology, Mercy Springfield
Dr. Carlson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2055 S Fremont Ave
Ste 200
Springfield, MO 65804Phone+1 417-820-3554Fax+1 417-820-3587- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Gynecologic Oncology, 1991 - 1994
- William Beaumont Army Medical CenterResidency, Obstetrics and Gynecology, 1987 - 1991
- Texas College of Osteopathic MedicineClass of 1987
Certifications & Licensure
- MO State License 2011 - 2025
- MI State License 2004 - 2013
- IA State License 2009 - 2011
- TX State License 1988 - 2007
- MN State License 1991 - 2007
- DC State License 2001 - 2004
- MD State License 1999 - 2004
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva Start of enrollment: 2003 Jan 01
Completed
Phase 3
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
- Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Unknown status
Not Applicable
- Home-Based Programs for Improving Sleep in Cancer Survivors Start of enrollment: 2010 Apr 01
Terminated
Phase 2
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
Completed
Not Applicable
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
Active, not recruiting
Phase 3
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Active, not recruiting
Phase 2
- S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
- Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy Start of enrollment: 2012 Jul 16
Completed
Phase 2
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
- Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Start of enrollment: 2012 Jun 18
Completed
Phase 3
- Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3
- Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
Active, not recruiting
Phase 2
- Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer Start of enrollment: 2012 Dec 06
Completed
Phase 2
- Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
- Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer Start of enrollment: 2012 Oct 01
Active, not recruiting
Not Applicable
- Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
- Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma Start of enrollment: 2013 Jun 01
Completed
Phase 3
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
Completed
Phase 3
- Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery Start of enrollment: 2013 Jul 31
Completed
Phase 2
- Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
- Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20
Active, not recruiting
Phase 2
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Active, not recruiting
Phase 2
- Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
- Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Start of enrollment: 2014 Jan 22
Active, not recruiting
Phase 2
- S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma Start of enrollment: 2013 Oct 01
Completed
Phase 2
- Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
- Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
Completed
Phase 2
- Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
Active, not recruiting
Phase 3
- Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Start of enrollment: 2014 Feb 14
Terminated
Phase 2
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
- Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Start of enrollment: 2014 Mar 21
Completed
Phase 3
- Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
- Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Start of enrollment: 2014 Feb 27
Active, not recruiting
Phase 2, Phase 3
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
Active, not recruiting
Phase 3
- S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Start of enrollment: 2014 May 01
Terminated
Phase 3
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
- Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Start of enrollment: 2015 Feb 11
Active, not recruiting
Phase 3
- Dabrafenib and Trametinib for the Treatment of Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Sep 19
Active, not recruiting
Phase 2
- A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
Recruiting
Phase 2, Phase 3
- Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Start of enrollment: 2015 Aug 27
Completed
Phase 2
- S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Start of enrollment: 2015 May 07
Active, not recruiting
Phase 2, Phase 3
- Collection and Storage of Tissue and Blood Samples From Patients With Cancer Start of enrollment: 2015 May 19
Recruiting
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Recruiting
Phase 3
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
- Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil Start of enrollment: 2017 May 30
Completed
Phase 3
- Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Aug 01
Recruiting
Phase 2
- Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
Active, not recruiting
Phase 2
- Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
- Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26
Active, not recruiting
Phase 3
- Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer Start of enrollment: 2019 Jul 24
Active, not recruiting
Not Applicable
- Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Start of enrollment: 2019 May 14
Active, not recruiting
- Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 May 17
Active, not recruiting
Phase 2
- Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol Start of enrollment: 2020 Jan 15
Recruiting
Phase 1
- Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer Start of enrollment: 2019 Sep 23
Recruiting
- S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration Start of enrollment: 2019 Aug 13
Recruiting
Phase 3
- Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer Start of enrollment: 2020 Jun 17
Recruiting
Phase 2, Phase 3
- Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker Start of enrollment: 2020 Jul 20
Active, not recruiting
Phase 2
- A Study of miRNA 371 in Patients With Germ Cell Tumors Start of enrollment: 2020 Jul 28
Recruiting
- Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer Start of enrollment: 2020 Dec 09
Terminated
Phase 3
- Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults Start of enrollment: 2021 Jan 25
Recruiting
Phase 3
- Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases Start of enrollment: 2021 Jun 08
Recruiting
Phase 2
- Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses Start of enrollment: 2021 Oct 12
Recruiting
Not Applicable
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsStandardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancersSandra A. Russo, Joan L. Walker, Jay W. Carlson, Jeanne Carter, Leigh C. Ward, Allan Covens, Edward J. Tanner, Jane M. Armer, Sheila H. Ridner, Sandi Hayes, Alphonse G...> ;Gynecologic Oncology. 2021 Feb 1
- 31 citationsGOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability...Jeanne Carter, Helen Q. Huang, Jane M. Armer, Jay W. Carlson, Suzy Lockwood, Susan Nolte, James Kauderer, Alan D. Hutson, Joan L. Walker, Aimee C. Fleury, Albert J. Bo...> ;Gynecologic Oncology. 2021 Jan 1
- 26 citationsGOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower...Jeanne Carter, Helen Q. Huang, Jane M. Armer, Jay W. Carlson, Suzy Lockwood, Susan Nolte, Bob R. Stewart, James Kauderer, Alan D. Hutson, Joan L. Walker, Aimee C. Fleu...> ;Gynecologic Oncology. 2019 Dec 1
- 19 citationsA randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritone...Ursula A. Matulonis, Michael W. Sill, Vicky Makker, David G. Mutch, Jay W. Carlson, Christopher J. Darus, Robert S. Mannel, David Bender, Erin K. Crane, Carol Aghajanian> ;Gynecologic Oncology. 2019 Mar 1
- 89 citationsA phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent end...Carol Aghajanian, Virginia L. Filiaci, Don S. Dizon, Jay W. Carlson, Matthew A. Powell, Angeles Alvarez Secord, Krishnansu S. Tewari, David Bender, David M. O'Malley, ...> ;Gynecologic Oncology. 2018 Aug 1
- 12 citationsPre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncol...Amina Ahmed, Wei Deng, William P. Tew, David Bender, Robert S. Mannel, Ramey D. Littell, Albert S. DeNittis, Mitchell I. Edelson, Mark A. Morgan, Jay W. Carlson, Chris...> ;Gynecologic Oncology. 2018 Aug 1
- 55 citationsGOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patientsJay W. Carlson, James Kauderer, Alan D. Hutson, Jeanne Carter, Jane M. Armer, Suzy Lockwood, Susan Nolte, Bob R. Stewart, Lari Wenzel, Joan L. Walker, Aimee C. Fleury,...> ;Gynecologic Oncology. 2018 Jun 1
- 8 citationsA quality process study of lymph node evaluation in endometrial cancer.Gareth K. Forde, Jay W. Carlson, Gordon O. Downey, Barbara J. Doss, Allen Shoemaker, Charles R. Harrison> ;International Journal of Gynecological Pathology. 2011 Jul 1
- 10 citationsBilateral and multinodular signet-ring stromal tumor of the ovary.Gareth K. Forde, Charles R. Harrison, Barbara J. Doss, Aviane E. Forde, Jay W. Carlson> ;Obstetrics and Gynecology. 2010 Aug 1
- 25 citationsNeoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.Leigh G. Seamon, Gordon O. Downey, Charles R. Harrison, Barbara J. Doss, Jay W. Carlson> ;Gynecologic Oncology. 2009 Sep 1
- 26 citationsAdvanced cytoreductive surgery: American perspectiveOliver Zivanovic, Amadeo Aldini, Jay W. Carlson, Dennis S. Chi> ;Gynecologic Oncology. 2009 Aug 1
- 3 citationsMultidisciplinary panel discussion of a gynecologic oncology patient: preventing wound complications.Jay W. Carlson, Alexander Stojadinovic, William J. Ennis, Robert F. Diegelmann, Christopher E. Attinger> ;Gynecologic Oncology. 2008 Nov 1
- 73 citationsTopical advances in wound careAlexander Stojadinovic, Jay W. Carlson, Gregory S. Schultz, Thomas A. Davis, Eric A. Elster> ;Gynecologic Oncology. 2008 Nov 1
- 78 citationsA randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study.Jay W. Carlson, James Kauderer, Joan L. Walker, Michael A. Gold, David M. O'Malley, Erin Tuller, Daniel L. Clarke–Pearson> ;Gynecologic Oncology. 2008 Jul 1
- 647 citationsPrognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyWilliam E. Winter, G. Larry Maxwell, Chunqiao Tian, Jay W. Carlson, Robert F. Ozols, Peter G. Rose, Maurie Markman, Deborah K. Armstrong, Franco M. Muggia, William McG...> ;Journal of Clinical Oncology. 2007 Aug 20
- 31 citationsThe utility of hand-assisted laparoscopy in ovarian cancer.Thomas C. Krivak, John C. Elkas, G. Scott Rose, William E. Winter, Jay W Carlson, Paul J. MacKoul> ;Gynecologic Oncology. 2005 Jan 1
- 45 citationsAssociation of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study.William E. Winter, G.Larry Maxwel, Chunqiao Tian, Eugene Sobel, G. Scott Rose, Gillian Thomas, Jay W Carlson> ;Gynecologic Oncology. 2004 Aug 1
- 13 citationsLaparoscopic exposure in obese high-risk patients with mechanical displacement of the abdominal wall.Michael P. Stany, William E. Winter, Louis A. Dainty, Ernest G. Lockrow, Jay W. Carlson> ;Obstetrics and Gynecology. 2004 Feb 1
- 44 citationsClinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus.William E. Winter, Jeffrey D. Seidman, Thomas C. Krivak, Suman Chauhan, Jay W Carlson, G. Scott Rose, Michael J. Birrer> ;Gynecologic Oncology. 2003 Oct 1
- 2 citationsThe utility of gastrojejunostomy in secondary cytoreduction and palliation of proximal intestinal obstruction in recurrent ovarian cancerWilliam E. Winter, John W. McBroom, Jay W Carlson, G. Scott Rose, John C. Elkas> ;Gynecologic Oncology. 2003 Oct 1
- 28 citationsAsian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer.Edward R. Kost, Kevin L. Hall, Jeffrey F. Hines, John H. Farley, Lawrence R. Nycum, G. Scott Rose, Jay W Carlson, Joseph R Fischer, Brian S. Kendall> ;Gynecologic Oncology. 2003 May 1
- Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.Farley, J.H., Hickey, K.W., Carlson, J.W., Rose, G.S., Kost, E.R., Harrison, T.A.> ;Cancer. 2003 May 1
- 34 citationsCosts and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries.G. Larry Maxwell, Jay W Carlson, Mark Ochoa, Tom Krivak, G. Scott Rose, Evan R. Myers> ;Obstetrics and Gynecology. 2002 Oct 1
- 9 citationsSuccessful management of metastatic placental site trophoblastic tumor with multiple pulmonary resections.Nicole L. Carlson, William E. Winter, Thomas C. Krivak, Barbara A. Crothers, Cynthia Macri, Jay W Carlson> ;Gynecologic Oncology. 2002 Oct 1
- 2 citationsModified technique for urinary diversion with incontinent conduits.William E. Winter, Thomas C. Krivak, G. Larry Maxwell, John C. Elkas, G. Scott Rose, Jay W Carlson> ;Gynecologic Oncology. 2002 Sep 1
- Join now to see all
Press Mentions
- Mercy Launches AI-Driven Texting Program to Prevent Chemo-Related HospitalizationsNovember 16th, 2023
Professional Memberships
- Member
- Fellow
Hospital Affiliations
- Mercy Hospital SpringfieldSpringfield, Missouri
- Mercy Hospital Fort SmithFort Smith, Arkansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
Similar Physicians & HCPs
Book an appointment with Dr. Jacob Christian
IntermountainDoximity / States / Missouri / Springfield / Jay Carlson, DO
Dr. Jay Carlson, Dr. Jay Carlson, DO, Dr. J Carlson, Dr. Jay W Carlson